Sector
PharmaceuticalsOpen
₹57.51Prev. Close
₹58.62Turnover(Lac.)
₹27.04Day's High
₹58.43Day's Low
₹55.6852 Week's High
₹74.852 Week's Low
₹31.35Book Value
₹46.84Face Value
₹10Mkt Cap (₹ Cr.)
158.42P/E
29.19EPS
2.01Divi. Yield
0Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Equity Capital | 32.99 | 30.02 | 27.7 | 25.7 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 99.79 | 87.39 | 85.94 | 73.16 |
Net Worth | 132.78 | 117.41 | 113.64 | 98.86 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Revenue | 348.41 | 300.08 | 349.34 | 395.96 |
yoy growth (%) | 16.1 | -14.1 | -11.77 | 60.94 |
Raw materials | -337.79 | -290.18 | -337.36 | -382.98 |
As % of sales | 96.95 | 96.69 | 96.56 | 96.72 |
Employee costs | -0.39 | -0.39 | -0.38 | -0.33 |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Profit before tax | 8.3 | 7.24 | 8.19 | 7.97 |
Depreciation | -0.92 | -0.89 | -0.71 | -0.64 |
Tax paid | -1.78 | -1.44 | -2.01 | -2.5 |
Working capital | 6.66 | 26.65 | 23.78 | 5.56 |
Other operating items |
Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 16.1 | -14.1 | -11.77 | 60.94 |
Op profit growth | 43.51 | -57.69 | -20.51 | 848.64 |
EBIT growth | 18.89 | -10.71 | -17.84 | 248.55 |
Net profit growth | 12.44 | -6.21 | 12.85 | 324.54 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,787.4 | 137.43 | 4,32,960 | 1,181.05 | 0.75 | 5,985.33 | 98.33 |
Divis Laboratories Ltd DIVISLAB | 6,012.5 | 79.59 | 1,65,003.32 | 594 | 0.48 | 2,297 | 513.62 |
Cipla Ltd CIPLA | 1,525.9 | 26.92 | 1,25,285.64 | 1,438.15 | 0.84 | 4,134.87 | 360.73 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,238.9 | 61.67 | 1,12,502.67 | 485 | 0.84 | 2,330 | 222.38 |
Mankind Pharma Ltd MANKIND | 2,557.5 | 55.53 | 1,07,385.94 | 416.38 | 0 | 2,396.57 | 334.17 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Managing Director
Mihir R Ghatalia
Independent Director
Chetan K Mehta
Independent Director
Lalit Tulsiani
Executive Director
Nimit R Ghatalia
Independent Director
Anil Mandal
Non Executive Director
Bina Ghatalia
Company Sec. & Compli. Officer
KAILASH CHAND JETHLIA
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Aarey Drugs & Pharmaceuticals Ltd
Summary
Aarey Drugs & Pharmaceuticals Ltd was originally incorporated on May 15, 1990 as a private limited company in Mumbai with the name Niharika Textiles & Chemicals Pvt Ltd. The company was originally promoted by Prakash Mandhana, Kavita Mandhana and Neeta Mandhana. In March, 1993, the Aarey Group of companies belonging to Ghatalia family took over the company and the company was converted into public limited company. Also, the name of the company was changed from Niharika Textiles & Chemicals Pvt Ltd to Aarey Drugs & Pharmaceuticals Ltd.The Company is one of the manufacturer and suppliers of pharmaceutical raw materials, Chemicals, Pharmaceuticals ingredients, APIs Drugs, Food Colours and Flavours. The company is engaged in the business of manufacturing, selling of drugs & pharmaceutical products and is governed by a number of central and state legislations that regulate the business. Apart from the bulk drug manufacturing activity, they also undertake importing & distributing of various industrial chemicals & solvents throughout the country. The company has their manufacturing unit located at Thane.The companys products include Methyl Nitro Imidazole, Metronidazole & Metronidazole Benzoate. Their pharmaceutical products are sourced from the authentic vendors to assure the quality and effectiveness. The pharmaceutical products offered by the company are in compliance with IP/ BP/ CP/ USP standards. They have their registered office is located at Thane and their corporate office
Read More
The Aarey Drugs & Pharmaceuticals Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is ₹55.87 today.
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Aarey Drugs & Pharmaceuticals Ltd is ₹158.42 Cr. as of 25 Apr ‘25
The PE and PB ratios of Aarey Drugs & Pharmaceuticals Ltd is 29.19 and 1.21 as of 25 Apr ‘25
The 52-week high/low is the highest and lowest price at which a Aarey Drugs & Pharmaceuticals Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Aarey Drugs & Pharmaceuticals Ltd is ₹31.35 and ₹74.8 as of 25 Apr ‘25
Aarey Drugs & Pharmaceuticals Ltd's CAGR for 5 Years at 6.22%, 3 Years at 9.83%, 1 Year at 15.51%, 6 Month at -2.41%, 3 Month at 20.74% and 1 Month at 54.87%.
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.